FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 22.35B +9.2% |
| Revenue (ttm) | 6.13B +6.4% |
| Net Income | 1.13B -1.3% |
| EPS | 46.05 +2.8% |
| Shares Out | 24.42M |
| PE Ratio | 19.87 |
| Forward PE | 15.97 |
| Dividend | 27.00 (3.30%) |
| Ex-Dividend Date | Dec 29, 2026 |
| Volume | 119,500 |
| Open | 875.00 |
| Previous Close | 875.00 |
| Day's Range | 869.00 - 915.00 |
| 52-Week Range | 717.00 - 1,011.00 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 12, 2026 |
About FINDEX
FINDEX Inc. offers medical devices in Japan. It operates through Medical Business, Public Business, and Healthtech Business segments. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big data search system, FAXde regional collaboration FAX ref... [Read more]
Financial Performance
In 2025, FINDEX's revenue was 6.11 billion, an increase of 4.59% compared to the previous year's 5.84 billion. Earnings were 1.26 billion, an increase of 8.09%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.